Price $58.07 |
Market Cap
89.45B
|
Sector Health Care |
Div. Growth
20.10%
|
|
P/E
10.6
|
P/B
1.22
|
P/S
0.26
|
Dividend %
3.40%
|
|
P/CF
-
|
P/FCF
10.9
|
Op. Cash Flow
14.11M
|
FCF
6.4
|
|
Op. Margin
4.00%
|
Net Margin
2.50%
|
ROE
11.90%
|
ROI
5.10%
|
|
ROA
3.60%
|
EPS Growth
166.60%
|
Current Ratio
0.9
|
Debt/Equity
71.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
